Prosight Management, LP Care Dx, Inc. Transaction History
Prosight Management, LP
- $378 Million
- Q3 2025
A detailed history of Prosight Management, LP transactions in Care Dx, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 504,030 shares of CDNA stock, worth $8.03 Million. This represents 1.94% of its overall portfolio holdings.
Number of Shares
504,030
Previous 302,808
66.45%
Holding current value
$8.03 Million
Previous $5.92 Million
23.87%
% of portfolio
1.94%
Previous 1.6%
Shares
4 transactions
Others Institutions Holding CDNA
# of Institutions
201Shares Held
54.5MCall Options Held
150KPut Options Held
57.6K-
Black Rock Inc. New York, NY5.29MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.75MShares$59.8 Million0.0% of portfolio
-
Bamco Inc New York, NY3.16MShares$50.3 Million0.13% of portfolio
-
State Street Corp Boston, MA2.57MShares$40.9 Million0.0% of portfolio
-
Ophir Asset Management Pty LTD2.2MShares$35 Million4.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $852M
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...